The analysis shows that ADAM11 expression is significantly lower in most solid tumors (Figure 9A), including the neural crest-derived melanoma, and this is even more pronounced in invasive breast carcinoma, a type of tumor where ADAM11/MDC was originally found mutated, supporting the hypothesis that ADAM11 may be a tumor suppressor gene. This evidence concerns the gene ADAM11 and neoplasm.